0001104659-26-039216
SEC filingQ1 FY2026 net loss widened to -$7.1M (-94.9% YoY) from -$3.6M, driven by non-cash derivative fair value adjustments and increased Ambler Metals equity losses amid higher activity and strategic personnel additions, while cash burn reflected budgeted project funding offset by equity raises.
The wider Q1 FY2026 net loss of -$7.1 million compared to -$3.6 million in the prior year reflects increased non-cash charges and operational ramp-up at the Ambler Metals joint venture. Management highlights that the increase in net loss is primarily driven by two non-cash items, including the mark-to-market fair value adjustment for the derivative liability related to the obligation to issue shares and warrants. This adjustment underscores the volatility in equity-linked instruments, where fair value changes directly impact reported earnings without affecting cash position.
The loss is also impacted by an increase in activity at Ambler Metals, which resulted in a larger amount for Trilogy's share of loss on the equity investment. This reflects Trilogy's strategic commitment to advancing the joint venture, where heightened operational tempo necessitates greater funding and generates proportional equity method losses. Concurrently, personnel costs rose due to the addition of senior staff across strategic advisory, corporate development, investor relations, and communications. These hires expand corporate management capabilities to support increased oversight of joint venture activities, strengthen stakeholder engagement, and improve the ability to advance long-term strategic initiatives.
Operating expenditures were driven primarily by corporate salaries, professional fees, and annual regulatory filing fees. Elevated stock-based compensation further contributed, as the Black-Scholes option pricing model relies on input estimations for expected life, volatility, and forfeiture rates, which can significantly influence the valuation and resulting expense recorded.